Document details

Thiopurines: Use them or lose them? International survey on current and future use of thiopurines in inflammatory bowel disease

Author(s): Sousa, Paula ; Ministro, Paula ; Armuzzi, Alessandro ; Dignass, Axel ; Høivik, Marte Lie ; Barreiro-de Acosta, Manuel ; Vavricka, Stephan ; Saad-Hossne, Rogério [UNESP] ; Gustavo Kotze, Paulo ; Peyrin-Biroulet, Laurent ; Magro, Fernando

Date: 2022

Persistent ID: http://hdl.handle.net/11449/229052

Origin: Oasisbr

Subject(s): Crohn's disease; Inflammatory bowel disease; Precision medicine; Thiopurines; Ulcerative colitis


Description

Made available in DSpace on 2022-04-29T08:30:08Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-01-01

Background and aims: The role of thiopurines in therapeutic algorithms of Crohn's disease (CD) and Ulcerative colitis (UC) is being questioned. This work aimed to investigate current practice and future perspectives of Inflammatory Bowel Disease (IBD) physicians regarding the efficacy, safety, and role of precision medicine with thiopurines in IBD. Methods: A 29-questions web-based survey was developed and distributed to IBD physicians worldwide. Results: We collected the complete answers of 408 physicians from 50 countries. Most participants were experienced physicians in IBD; 26.0% met our definition of “IBD expert”. Four physicians reported to not use thiopurines in clinical practice. Most respondents used thiopurines in monotherapy and in combination therapy, both in CD and UC. Respondents tended to consider thiopurines as drugs with a good safety profile, with the agreement of 61.5% of the overall cohort. A minority of physicians (~6%) considered that thiopurines will not be used in the future in IBD patients, while 57.8% believed that these drugs will still be used, in mono and combination therapy. Conclusion: Despite the many emerging treatments in IBD, according to the beliefs of most physicians surveyed, thiopurines will still be an important part of the treatment algorithm of both CD and UC.

Department of Gastroenterology Viseu Unit Tondela-Viseu Hospital Centre

IBD Center Fondazione Policlinico Universitario A. Gemelli IRCCS Universita Cattolica

Department of Medicine I Agaplesion Markus Hospital Goethe-University

Department of Gastroenterology Oslo University Hospital

IBD Unit Department of Gastroenterology Hospital Clínico Universitario de Santiago de Compostela

Division of Gastroenterology and Hepatology University Hospital

Department of Internal Medicine São Paulo State University (Unesp) Medical School

Colorectal Surgery Unit IBD outpatient clinics Catholic University of Paraná (PUCPR)

Department of Gastroenterology and Inserm NGERE U1256 University Hospital of Nancy University of Lorraine

Department of Biomedicine Unit of Pharmacology and Therapeutics University of Porto

Department of Gastroenterology São João University Hospital

MedInUP Centre for Drug Discovery and Innovative Medicines

Department of Internal Medicine São Paulo State University (Unesp) Medical School

Document Type Journal article
Language English
facebook logo  linkedin logo  twitter logo 
mendeley logo

Related documents

No related documents